Literature DB >> 3733857

Role of culture conditions and exposure duration in determining sensitivity of human bone marrow progenitor cells to methotrexate.

G E Umbach, G Spitzer, J A Ajani, V Hug, H Thames, F B Rudolph, B Drewinko.   

Abstract

The effect of drug concentration, exposure duration, and culture conditions on the cytotoxic activity of methotrexate (MTX) on normal granulocyte-macrophage colony-forming units in culture (GM-CFUC) was studied using a bilayer soft agar system with nucleoside-free medium. The degree of inhibition of colony formation depended on the type of serum supplementation. A 1 h or 2 h pulse treatment with 2 X 10(-4) M (100 micrograms/ml) MTX failed to kill GM-CFUC, when the cells were subsequently plated in a system containing 15% undialyzed fetal bovine serum (FBS). For continuous exposure the observed LD50 of MTX in the agar system was higher than 10(-4) M for 15% undialyzed FBS, 10(-5) M for 15% dialyzed FBS plus 0.25% undialyzed FBS, 10(-6) M for 15% dialyzed FBS, and 10(-8) M for 15% undialyzed horse serum. The difference for dialyzed FBS versus horse serum can be explained by differences in nucleoside concentrations. The difference for dialyzed FBS versus horse serum may be secondary to an enhancer of MTX in horse serum. For studying MTX sensitivity of human tumor cells in vitro, we suggest testing conditions that lie within the dose survival curve of GM-CFUC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733857     DOI: 10.1007/bf00389244

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  16 in total

1.  Colony stimulating factor augmentation in human placental conditioned medium.

Authors:  D S Verma; G Spitzer; M Beran; A R Zander; K B McCredie; K A Dicke
Journal:  Exp Hematol       Date:  1980-08       Impact factor: 3.084

2.  Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity.

Authors:  H M Pinedo; B A Chabner
Journal:  Cancer Treat Rep       Date:  1977-07

3.  The growth of mouse bone marrow cells in vitro.

Authors:  T R Bradley; D Metcalf
Journal:  Aust J Exp Biol Med Sci       Date:  1966-06

4.  Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity.

Authors:  S B Howell; S J Mansfield; R Taetle
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

5.  Simple and rapid high-performance liquid chromatographic method for analysis of nucleosides in biological fluids.

Authors:  R P Agarwal; P P Major; D W Kufe
Journal:  J Chromatogr       Date:  1982-09-10

6.  A radioassay for serum folate: use of a two-phase sequential-incubation, ligand-binding system.

Authors:  S P Rothenberg; M DaCosta; Z Rosenberg
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

7.  5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.

Authors:  H P Lohrmann; K A Lepp; W Schreml
Journal:  J Natl Cancer Inst       Date:  1982-04       Impact factor: 13.506

8.  Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.

Authors:  H Nederbragt; M P Uitendaal; L van der Grint; A Leyva; H M Pinedo
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

9.  Prospective clinical trial of a human tumor cloning system.

Authors:  D D Von Hoff; G M Clark; B J Stogdill; M F Sarosdy; M T O'Brien; J T Casper; D E Mattox; C P Page; A B Cruz; J F Sandbach
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

10.  Clinical application of the clonogenic assay.

Authors:  D H Kern; C A Bertelsen; B D Mann; M A Campbell; D L Morton; A J Cochran
Journal:  Ann Clin Lab Sci       Date:  1983 Jan-Feb       Impact factor: 1.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.